Хагажеева Мадина Назировна
Russian Cancer Research Center NN Blokhin · 23 works · 34 citations · h-index 3
Top works
- THE PROSPECTS FOR THE USE OF microRNA AS DIAGNOSTIC AND PROGNOSTIC MELANOMA BIOMARKERS
- The role of interleukin-6 and hepcidin 25 in the pathogenesis of anemic syndrome associated with malignant neoplasms with breast cancer patients before neoadjuvant chemotherapy
- THE ROLE OF HEPCIDIN 25 IN THE DEVELOPMENT OF ANEMIC SYNDROME ASSOCIATED WITH MALIGNANT DISEASES
- Peculiarities of iron metabolism in patients with breast cancer before adjuvant chemotherapy
- Atezolizumab and bevacizumab in the treatment of advanced hepatocellular cancer with adverse factors and tumor thrombosis
- MicroRNA and their role in pathogenesis and diagnosis of breast cancer
- DIAGNOSTICS AND TREATMENT OF ANEMIC SYNDROME IN PATIENTS WITH BREAST CANCER ON THE BACKGROUND OF NEOADJUVANT CHEMOTHERAPY
- Studying the effect of high-protein nutritional support on postoperative outcomes and during adjuvant chemotherapy in patients with primary gastric cancer
- Treatment of anemic syndrome in patients receiving surgical and chemotherapeutic treatment for breast and colorectal cancer
- Assessment of iron metabolism disorders and adequate treatment of anemic syndrome in patients with breast cancer on the background of adjuvant chemotherapy
- Изучение влияния высокобелковой нутритивной поддержки на послеоперационные исходы и в процессе адъювантной химиотерапии у больных первичным раком желудка
- Effectiveness and safety of Atezolizumab and Bevacizumab as conversion therapy for unresectable or advanced HCC in real-world clinical practice in Russia: Multicenter retrospective observational study
- Отдаленные результаты применения дурвалумаба после химиолучевой терапии в лечении местнораспространенного нерезектабельного немелкоклеточного рака легкого в России
- Атезолизумаб и бевацизумаб в лечении распространенного гепатоцеллюлярного рака с неблагоприятными факторами и опухолевым тромбозом
- Nivolumab with Ipilimumab in the treatment of refractory hepatocellular carcinoma
- Pemigatinib in the real-world management of advanced intrahepatic FGFR2-positive cholangiocarcinoma
- Особенности анемического синдрома у больных с колоректальным раком
- 170P Efficacy of the combination of transarterial chemoembolization (TACE) and immunotherapy of atezolizumab + bevacizumab in patients before liver resection and transplantation (OTP) with hepatocellular carcinoma (HCC)
- Лечение анемического синдрома у пациентов, получающих хирургическое и химиотерапевтическое лечение по поводу рака молочной железы и колоректального рака
- Long-term outcomes of durvalumab after chemoradiotherapy in locally advanced non-small cell lung cancer in Russia